News

The contracts for drug development, valued at $56.3m were awarded to Neumedicines, RxBio, the University of Arkansas for Medical Sciences of Little Rock, Araim Pharmaceuticals of Ossining and

As per the terms of the deal, Galderma will acquire substantially all of Graceway’s assets including inventory and intellectual property rights and will assume the majority of Graceway’s

Northera is indicated as a treatment of symptomatic neurogenic orthostatic hypotension (NOH) in patients with primary autonomic failure, dopamine beta hydroxylase deficiency and non-diabetic autonomic neuropathy. The NDA

The Phase 1 dose escalation portion of the trial aims to investigate a single injection of different HTI-501 formulations into dimpled lesions of the skin followed by a

The affiliates of J&J include McNEIL-PPC, McNEIL MMP, LLC, and Johnson & Johnson. Following the agreement, J&J will own the venture’s assets which comprise exclusive rights to market

Cue-Mare is used for the induction of estrous in spring transitional mares, which is particularly important to enable early breeding. Tri-Otic Ointment is a canine treatment for acute

The acquisition allows Sony to boost up its own research and development, particularly for Point of Care diagnostic equipment and also to commercialize these products. Micronics will become

Most recently, Kelly worked as the chief commercial officer for BioVex, and was responsible for leading the company’s commercial efforts. Prior to BioVex, Kelly was the founder and

The company claims FenuLife is a completely natural fenugreek fiber that can act as a prophylactic treatment for heartburn and reflux symptoms. In addition to the prophylactic function,